Exercise medicine to arrest bone loss in men with prostate cancer undergoing androgen deprivation therapy: a 12-month randomized controlled trial

Robert U. Newton, Daniel A. Galvao, Nigel Spry, David Joseph, Suzanne K. Chambers, Robert A. Gardiner, Dickon Hayne, Nicolas H. Hart, Brad A. Wall, Kate A. Bolam, Dennis R. Taaffe

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)15-15
Number of pages1
JournalBJU International
Volume120
Publication statusPublished - Aug 2017
Externally publishedYes
Event18th Asia-Pacific Prostate Cancer Conference - Melbourne Convention and Exhibition Centre, Melbourne, Australia
Duration: 30 Aug 20172 Sep 2017

Cite this

Newton, R. U., Galvao, D. A., Spry, N., Joseph, D., Chambers, S. K., Gardiner, R. A., Hayne, D., Hart, N. H., Wall, B. A., Bolam, K. A., & Taaffe, D. R. (2017). Exercise medicine to arrest bone loss in men with prostate cancer undergoing androgen deprivation therapy: a 12-month randomized controlled trial. BJU International, 120, 15-15.